Effectiveness of TAS-102 in patients with metastatic colorectal cancer in a single comprehensive cancer center

被引：0
|
作者：
Sales, C. [1 ]
Juliao, I. [1 ]
Rosinha, A. [1 ]
Marques, D. [1 ]
Carneiro, F. [2 ]
Faustino, C. [3 ]
Machado, M. [1 ]
Ferreira, P. [4 ]
Fragoso, M. [1 ]
Sousa, N. [4 ]
机构：
[1] IPO Porto, Porto, Portugal
[2] Portuguese Inst Oncol FG Porto, Portugal Med Oncol Serv, Porto, Portugal
[3] Inst Portugues Oncol Porto, Porto, Portugal
[4] Portuguese Inst Oncol, Porto, Portugal
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 279
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [1] TAS-102 in metastatic colorectal cancer
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2018, 19 (01): : E18 - E18
  • [2] Treatment of TAS-102 in patients with metastatic colorectal cancer
    Ota, Takayo
    Tsukuda, Hiroshi
    Hasegawa, Yoshikazu
    Miyatake, Nozomi
    Suzumura, Tomohiro
    Fukuoka, Masahiro
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [3] Cost-effectiveness of TAS-102 plus bevacizumab versus TAS-102 monotherapy in patients with metastatic colorectal cancer
    Sugiura, Kiyoaki
    Seo, Yuki
    Takahashi, Takayuki
    Tokura, Hideyuki
    Ito, Yasuhiro
    Tanaka, Motomu
    Kishida, Norihiro
    Nishi, Yusuke
    Onishi, Yoshihiko
    Aoki, Hikaru
    [J]. BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [4] Cost-effectiveness of TAS-102 plus bevacizumab versus TAS-102 monotherapy in patients with metastatic colorectal cancer
    Kiyoaki Sugiura
    Yuki Seo
    Takayuki Takahashi
    Hideyuki Tokura
    Yasuhiro Ito
    Motomu Tanaka
    Norihiro Kishida
    Yusuke Nishi
    Yoshihiko Onishi
    Hikaru Aoki
    [J]. BMC Gastroenterology, 21
  • [5] TAS-102 for metastatic refractory colorectal cancer
    Cleghorn, Sean
    [J]. LANCET ONCOLOGY, 2015, 16 (07): : E314 - E314
  • [6] TAS-102 for the treatment of metastatic colorectal cancer
    Salvatore, Lisa
    Rossini, Daniele
    Moretto, Roberto
    Cremolini, Chiara
    Schirripa, Marta
    Antoniotti, Carlotta
    Marmorino, Federica
    Loupakis, Fotios
    Falcone, Alfredo
    Masi, Gianluca
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (11) : 1283 - 1292
  • [7] Retrospective analysis of TAS-102 for metastatic colorectal cancer
    Aoki, M.
    Shimamoto, F.
    Ikegami, T.
    Yamaguchi, T.
    Terazawa, T.
    Kii, T.
    Goto, M.
    Higuchi, K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [8] TAS-102 plus bevacizumab in metastatic colorectal cancer
    Colloca, Giuseppe A.
    Venturino, Antonella
    [J]. LANCET ONCOLOGY, 2020, 21 (05): : E226 - E226
  • [9] A novel antimetabolite: TAS-102 for metastatic colorectal cancer
    Miyamoto, Yuji
    Lenz, Heinz-Josef
    Baba, Hideo
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 355 - 365
  • [10] Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer
    Mayer, Robert J.
    Van Cutsem, Eric
    Falcone, Alfredo
    Yoshino, Takayuki
    Garcia-Carbonero, Rocio
    Mizunuma, Nobuyuki
    Yamazaki, Kentaro
    Shimada, Yasuhiro
    Tabernero, Josep
    Komatsu, Yoshito
    Sobrero, Alberto
    Boucher, Eveline
    Peeters, Marc
    Tran, Ben
    Lenz, Heinz-Josef
    Zaniboni, Alberto
    Hochster, Howard
    Cleary, James M.
    Prenen, Hans
    Benedetti, Fabio
    Mizuguchi, Hirokazu
    Makris, Lukas
    Ito, Masanobu
    Ohtsu, Atsushi
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (20): : 1909 - 1919
12345